Literature DB >> 18391686

Rheumatoid arthritis masked by docetaxel chemotherapy in a patient with ovarian carcinoma.

Marc A Callender1, Emmanuel S Antonarakis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18391686      PMCID： PMC4020428          DOI： 10.1097/RHU.0b013e31816b8728

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN： 1076-1608            Impact factor:   3.517


× No keyword cloud information.
  5 in total

1.  Remission of rheumatoid arthritis with taxol in a patient with breast carcinoma.

Authors:  W H Yoo; H S Baek
Journal:  J Rheumatol       Date:  2000-06       Impact factor: 4.666

2.  Paclitaxel selectively induces mitotic arrest and apoptosis in proliferating bovine synoviocytes.

Authors:  A Hui; G V Kulkarni; W L Hunter; C A McCulloch; T F Cruz
Journal:  Arthritis Rheum       Date:  1997-06

3.  Effects of paclitaxel on cultured synovial cells from patients with rheumatoid arthritis.

Authors:  A Kurose; W Yoshida; M Yoshida; T Sawai
Journal:  Cytometry       Date:  2001-08-01

Review 4.  New antiangiogenic strategies for the treatment of proliferative synovitis.

Authors:  Dahlia T Lainer; Ernest Brahn
Journal:  Expert Opin Investig Drugs       Date:  2005-01       Impact factor: 6.206

5.  Regression of collagen-induced arthritis with taxol, a microtubule stabilizer.

Authors:  E Brahn; C Tang; M L Banquerigo
Journal:  Arthritis Rheum       Date:  1994-06
  5 in total
  2 in total

1.  An evaluation of lower-body functional limitations among long-term survivors of 11 different types of cancers.

Authors:  Mario Schootman; Rebecca Aft; Donna B Jeffe
Journal:  Cancer       Date:  2009-11-15       Impact factor: 6.860

Review 2.  Activities and Molecular Mechanisms of Diterpenes, Diterpenoids, and Their Derivatives in Rheumatoid Arthritis.

Authors:  Muhammad Torequl Islam; Cristina Quispe; Jesús Herrera-Bravo; Md Mizanur Rahaman; Rajib Hossain; Chandan Sarkar; Md Abdur Raihan; Md Mashrur Chowdhury; Shaikh Jamal Uddin; Jamil A Shilpi; João Marcelo de Castro E Sousa; Ana Amélia de Carvalho Melo-Cavalcante; Mohammad S Mubarak; Javad Sharifi-Rad; Daniela Calina
Journal:  Evid Based Complement Alternat Med       Date:  2022-03-25       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.